Pacific Biosciences of California News

Pacific Biosciences Analyst Ratings

BenzingaApr 22 08:19 ET

Pacific Biosciences Analyst Ratings

BenzingaApr 18 12:54 ET

Pacific Biosciences Analyst Ratings

BenzingaApr 17 11:05 ET

Pacific Biosciences Analyst Ratings

BenzingaApr 10 09:31 ET

Pacific Biosciences Analyst Ratings

BenzingaFeb 16 13:32 ET

UBS Trims Pacific Biosciences of California Price Target to $12 From $12.50, Maintains Buy Rating

MT NewswiresFeb 16 12:45 ET

UBS Lifts Price Target on Pacific Biosciences of California to $12.50 From $10, Keeps Buy Rating

MT NewswiresJan 2 10:25 ET

Stephens & Co. Initiates Coverage On Pacific Biosciences With Overweight Rating, Announces Price Target of $11

BenzingaDec 14, 2023 05:53 ET

Pacific Biosciences Analyst Ratings

BenzingaDec 14, 2023 05:51 ET

Pacific Biosciences Analyst Ratings

BenzingaDec 13, 2023 05:22 ET

UBS Upgrades Pacific Biosciences to Buy, Lowers Price Target to $10

BenzingaNov 17, 2023 07:19 ET

Pacific Biosciences Analyst Ratings

BenzingaNov 17, 2023 07:18 ET

Piper Sandler Maintains Neutral on Pacific Biosciences, Lowers Price Target to $8

BenzingaNov 6, 2023 10:16 ET

Pacific Biosciences Analyst Ratings

BenzingaNov 6, 2023 10:15 ET

Cantor Fitzgerald Upgrades Pacific Biosciences to Overweight, Lowers Price Target to $11

BenzingaOct 31, 2023 10:37 ET

Pacific Biosciences Analyst Ratings

BenzingaOct 31, 2023 10:35 ET

Piper Sandler Reaffirms Their Hold Rating on Pacific Biosciences (PACB)

TipRanksOct 31, 2023 06:37 ET

Pacific Biosciences Analyst Ratings

BenzingaOct 24, 2023 08:33 ET

Piper Sandler Maintains Neutral on Pacific Biosciences, Lowers Price Target to $9

BenzingaOct 16, 2023 13:34 ET

Pacific Biosciences Analyst Ratings

BenzingaOct 16, 2023 13:33 ET